Leukotrienes

Application BLT-1 (Block lipid transport-1) has been used as an inhibitor of the SR-BI (scavenger receptor, class B, type I) mediated lipid transfer to determine if miR-223-3p export from polymorphonuclear neutrophils (PMNs) to high-density

BLT-1 (Block lipid transport-1) has been used as an inhibitor of the SR-BI (scavenger receptor, class B, type I) mediated lipid transfer to determine if miR-223-3p export from polymorphonuclear neutrophils (PMNs) to high-density lipoproteins (HDLs)

BLT-1 (Block lipid transport-1) has been used as an inhibitor of the SR-BI (scavenger receptor, class B, type I) mediated lipid transfer to determine if miR-223-3p export from polymorphonuclear neutrophils (PMNs) to high-density lipoproteins (HDLs)

BLT-1 (Block lipid transport-1) has been used as an inhibitor of the SR-BI (scavenger receptor, class B, type I) mediated lipid transfer to determine if miR-223-3p export from polymorphonuclear neutrophils (PMNs) to high-density lipoproteins (HDLs)

BLT-1 (Block lipid transport-1) has been used as an inhibitor of the SR-BI (scavenger receptor, class B, type I) mediated lipid transfer to determine if miR-223-3p export from polymorphonuclear neutrophils (PMNs) to high-density lipoproteins (HDLs)

Roquinimex is a quinoline derivative immunostimulant which increases NK cell activity and macrophage cytotoxicity: inhibits angiogenesis and reduces the secretion of TNF alpha.

Roquinimex is a quinoline derivative immunostimulant which increases NK cell activity and macrophage cytotoxicity: inhibits angiogenesis and reduces the secretion of TNF alpha.

Roquinimex is a quinoline derivative immunostimulant which increases NK cell activity and macrophage cytotoxicity: inhibits angiogenesis and reduces the secretion of TNF alpha.

Roquinimex is a quinoline derivative immunostimulant which increases NK cell activity and macrophage cytotoxicity: inhibits angiogenesis and reduces the secretion of TNF alpha.

Cell Line Origin Rat glial tumour Cell Line Description Derived from a rat glial tumour induced by N-nitrosomethylurea. The cells produce S-100 protein which is found in the neural tissue of vertebrates and has been found in brain tumours.

CJ-13,610 is an orally active and nonredox-type inhibitor of 5-lipoxygenase (5-LOX). CJ-13,610 inhibits the biosynthesis of leukotriene B4 and regulates the expression of IL-6 mRNA in macrophages.Application:CJ-13610 may be used to study

CJ-13,610 is an orally active and nonredox-type inhibitor of 5-lipoxygenase (5-LOX). CJ-13,610 inhibits the biosynthesis of leukotriene B4 and regulates the expression of IL-6 mRNA in macrophages.Application:CJ-13610 may be used to study